BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
This study has been completed.
Sponsor:
Cell Therapeutics
Information provided by (Responsible Party):
Cell Therapeutics
ClinicalTrials.gov Identifier:
NCT00088530
First received: July 28, 2004
Last updated: May 20, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2010 |
| Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
No publications provided by Cell Therapeutics
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):